Journals / Journal of the Turkish-German Gynecological Association / 2014 / Cilt: 15 - Sayı: 4

Effect of tamoxifen on ovarian reserve: A randomized controlled assessor-blind trial in a mouse model

Pages
228–232
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While the number of primordial (9 vs 8), primary (6 vs 3), and secondary (4.5 vs 5) follicles were similar, there were significantly fewer preantral (11.5 vs 6, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine whether tamoxifen (TMX) exposure causes a permanent decrease in ovarian reserve.
📊
Key Findings & Data:Material and Methods: A randomized controlled assessor-blind trial including 30 adult female inbred BALB/C mice.
💡
Conclusion & Impact:While the number of primordial (9 vs 8), primary (6 vs 3), and secondary (4.5 vs 5) follicles were similar, there were significantly fewer preantral (11.5 vs 6, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To determine whether tamoxifen (TMX) exposure causes a permanent decrease in ovarian reserve. Material and Methods: A randomized controlled assessor-blind trial including 30 adult female inbred BALB/C mice. Fifteen mice in the TMX group were given a single 0.1-mg dose of TMX intraperitoneally. Fifteen mice in the control group were given a single dose of the vehicle at the same volume intraperitoneally. Two cycles later, blood samples were collected for determination of anti-Müllerian hormone (AMH) levels, and the mice were sacrificed. After gonadectomy, ovarian size was measured, and follicles were counted under light microscopy. Results: Median serum AMH levels were 6.53 and 6.14 ng/ml in the control and TMX groups, respectively (p=0.03). Ovarian size was signifi- cantly decreased in the TMX group. While the number of primordial (9 vs 8), primary (6 vs 3), and secondary (4.5 vs 5) follicles were similar, there were significantly fewer preantral (11.5 vs 6, p

🔖

Cite This Article

AVCI, B., PEKER, S., ZİK, B., ÖZERKAN, K., TOPÇU, A. A., ATA, B. (2022). Effect of tamoxifen on ovarian reserve: A randomized controlled assessor-blind trial in a mouse model. Journal of the Turkish-German Gynecological Association, Cilt: 15 - Sayı: 4, 228–232. https://ajindex.com/articles/567573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 2008
  2. [CrossRef] 2.Early Breast Cancer Trialists’ Collaborative G. Effects of chemother- apy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005
  3. [CrossRef] 3.Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aro- matase inhibitors versus tamoxifen. J Clin Oncol 2010
  4. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington D.C.: National Academic Press
  5. Parrott JA, Skinner MK. Kit-ligand/stem cell factor induces pri- mordial follicle development and initiates folliculogenesis. Endocrinology 1999
  6. Oktay K, Schenken RS, Nelson JF. Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat. Biol Reprod 1995
  7. [CrossRef] 7.Matsuda A, Higuchi K, Karasawa M, Yoneyama S, Deguchi J, Miyamoto M. Fourteen-day oral combination dose toxicity study of CGS 16949 A (aromatase inhibitor) with 5-fluorouracil or tamoxifen in rats. J Toxicol Sci 1997
  8. [CrossRef] 8.Donath J, Nishino Y. Effects of partial versus pure antiestrogens on ovulation and the pituitary-ovarian axis in the rat. J Steroid Biochem Mol Biol 1998
  9. [CrossRef] 9.Cho SD, Kim JH, Kim DY, Lee YS, Kang KS. Pre-validation study for OECD enhanced test guideline 407 protocol by gavage for 4 weeks using propylthiouracil and tamoxifen. Toxicol Lett 2003
  10. [CrossRef] 10. Kennel P, Pallen C, Barale-Thomas E, Espuna G, Bars R. Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects. Arch Toxicol 2003
  11. [CrossRef] 11. Tsujioka S, Ban Y, Wise LD, Tsuchiya T, Sato T, Matsue K, et al. Collaborative work on evaluation of ovarian toxicity. 3) Effects of 2- or 4- week repeated-dose toxicity and fertility studies with tamoxifen in female rats. J Toxicol Sci 2009
  12. (34 Suppl 1): SP43-51. 12. Couse JF, Yates MM, Deroo BJ, Korach KS. Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology 2005
  13. [CrossRef] 13.